A dual institution real-world study of avelumab for advanced Merkel cell carcinoma

被引：0
|
作者：
Miller, David Michael
Wright, Kayla
Silk, Ann W.
Thakuria, Manisha
Shalhout, Sophia
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Avelumab Approved indication: Merkel cell carcinoma
    不详
    AUSTRALIAN PRESCRIBER, 2018, 41 (02) : 55 - 55
  • [22] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Matt Shirley
    Targeted Oncology, 2018, 13 : 409 - 416
  • [23] Immunotherapy in Merkel cell carcinoma: role of Avelumab
    Palla, Amruth R.
    Doll, Donald
    IMMUNOTARGETS AND THERAPY, 2018, 7 : 15 - 19
  • [24] Real-world clinical outcomes in avelumab-treated patients (pts) in the United States (US) from SPEAR-Merkel: Study informing treatment pathway decisions in Merkel cell carcinoma (MCC).
    Bhanegaonkar, Abhijeet
    Liu, Frank Xiaoqing
    Kim, Ruth
    Boyd, Marley
    Fulcher, Nicole
    Krulewicz, Stan
    Kasturi, Vijay
    Cowey, Charles Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [25] Real-world clinical outcomes in avelumab-treated patients (pts) in the United States (US) from SPEAR-Merkel -Study informing treatment Pathway dEcisions in Merkel cell cARcinoma (MCC).
    Cowey, Charles Lance
    Liu, Frank Xiaoqing
    Kim, Ruth
    Boyd, Marley
    Fulcher, Nicole
    Krulewicz, Stan
    Kasturi, Vijay
    Bhanegaonkar, Abhijeet
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Safety and effectiveness of avelumab in patients with curatively unresectable merkel cell carcinoma (MCC) in a real-world setting: A post-marketing surveillance in Japan.
    Uhara, Hisashi
    Kiyohara, Yoshio
    Sato, Masashi
    Endo, Shehla
    Song, Bingbing
    Sato, Yoshinori
    Tanaka, Yutaro
    Kambe, Anzu
    Yamazaki, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Real-world Merkel cell carcinoma outcomes from a tertiary care center.
    Canavan, Theresa N.
    Doudican, Nicole Adell
    Stevenson, Mary
    Pavlick, Anna C.
    Carucci, John
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Avelumab plus axitinib for first-line treatment of advanced renal cell carcinoma: A real-world ambispective RAVE-Renal study.
    Chubenko, Viacheslav
    Baklanova, Olga
    Kalpinskiy, Alexey
    Safina, Sufiia
    Lebedinets, Andrey
    Shkurat, Alexey
    Parsadanova, Elvira
    Turganova, Maria
    Petkau, Vladislav
    Tovbik, Natalya
    Tkacheva, Elena
    Anzhiganova, Yulia
    Novikova, Olga
    Bragina, Varvara
    Zukov, Ruslan
    Tsimafeyeu, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 117 - 117
  • [29] Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
    Bullement, Ash
    Nathan, Paul
    Willis, Anna
    Amin, Amerah
    Lilley, Cameron
    Stapelkamp, Ceilidh
    Hatswell, Anthony
    Pescott, Chris
    Bharmal, Murtuza
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 377 - 390
  • [30] Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
    Strum, Scott
    Climans, Seth
    Purcell, Victoria
    Black, Morgan
    Winquist, Eric
    Ernst, Scott
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
12345